Pfizer Inc, Chennai

At Pfizer, patients are at the heart of all that we do. So, developing breakthroughs that change patients’ lives is not just an aim, it is our very purpose! To do this, we bring together the best scientific minds and cutting-edge research techno scientific minds and cutting-edge research technology, to develop therapies that can prevent, treat or cure some of the most feared diseases of our time. We introduce these life-saving medicines in countries all over the world and in India. We have brought to this country many of our proven blockbuster medicines and vaccines. We were also the first pharmaceutical company to begin clinical research in India. We believe that is important for the vulnerable sections of society in India to have access to quality and innovative drugs. To that end, we work with governments, healthcare providers and local communities to increase access to reliable, affordable health care and strengthen India’s health system. Unleash the power of our people Pfizer Limited was established in 1950, and has a rich heritage of 70 years, successfully launching and supporting clinical developments across the country. Deliver first-in-class science We aim to create and source the best science in the world. We bring forward only our most promising and transformational products within our six therapeutic areas – with a focus on getting them to patients as quickly as possible. ​​​​​​​Transform our go-to-market model ​​​​​​​We are partnering with others to address the patient affordability challenge by exploring new, flexible payment approaches, including value-based agreements, and being bold in how we expand access to our medicines. ​​​​​​​Win the digital race in pharma ​​​​​​​We are using big data and such digital technologies as machine learning and artificial intelligence to expedite the drug discovery and development process and to enhance patient experiences and outcomes. Lead the conversation We engage with policymakers and other stakeholders to advocate for policies that allow innovation to flourish while ensuring patient access to the latest therapies – all while communicating the value our science brings to society. Courage Breakthroughs start by challenging convention, especially in the face of uncertainty or adversity. This happens when we think big, speak up and are decisive. Helix Image Excellence We can only change patients’ lives when we perform at our best together. This happens when we focus on what matters, agree who does what and measure our outcomes. Helix Image Equity We believe that every person deserves to be seen, heard and cared for. This happens when we are inclusive, act with integrity and reduce health care disparities.​​​​​​ Helix Image Joy We give ourselves to our work, but it also gives to us. We find joy when we take pride, recognize one another and have fun. Pfizer in India is just as old as India is as a republic, having begun its operations in the country in 1950. Over the years, we have introduced many of Pfizer’s global breakthrough and innovative treatments in several major therapeutic areas, while also developing one of the country’s leading local brands portfolios to benefit millions of patients and consumers. Pfizer operates in India through three legal entities: Pfizer Limited (listed on the Bombay Stock Exchange); Pfizer Products India Private Ltd (a 100% Pfizer Inc. subsidiary); and Pfizer Healthcare India Pvt. Ltd. (a 100% indirect subsidiary of Pfizer Inc focused on manufacturing and research). With over 5500 colleagues across these entities, covering commercial operations, global manufacturing, R&D, and other functions, we are committed to providing therapies to prevent, treat and cure some of the most important diseases that impact India and the world today. Pfizer’s operations in India comprise three manufacturing plants, two R&D centers and six regional centers for commercial operations and global support functions. Collectively, Pfizer in India is the fourth largest multinational pharmaceuticals company by revenue with a product portfolio of over 16 therapies, 3 manufacturing units with a combined capacity of 4.5 billion units; exports to over 50 countries and research in key areas such as Oncology, Immunology and Anti-infectives. ...view more